Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired bySun Pharma
Date11/2012

General Information

Websitedusapharma.com
CategoryBioTech
Phone978-657-7500
Employees

Offices

Wilmington, USA
25 Upton Drive
Wilmington, MA, 01887
USA

People

Board of Directors

Tags

DUSA Pharmaceuticals

DUSA Pharmaceuticals, Inc.® (NASDAQGM: DUSA) is a fully integrated specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® photodynamic therapy (PDT) technology platform used in conjunction with it’s proprietary light source, the BLU-U® Blue Light Photodynamic Therapy Illuminator. Levulan Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% in combination with the BLU-U is approved by the U.S. Food and Drug Administration for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp. Actinic Keratosis is the most frequently diagnosed skin disease by U.S. dermatologists. PDT is a two part process in which the target cells are made extremely sensitive to light and then exposed to blue light, which destroys the cells. The BLU-U, as a stand alone device, uses light to treat mild to moderate inflammatory acne. DUSA is based in Wilmington, MA.

Recent Milestones

Videos

Screenshots

DUSA Pharmaceuticals screenshot
Above: DUSA Pharmaceuticals
Uploaded: 11/9/12

Sources

  1. Sun Pharma to Acquire DUSA Pharmaceuticals, Inc. (in.finance.yahoo.com) [edit]
Edit This Page
Last Edited 12/26/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy